Well said @George1972
Stick around mate, we need to keep the FA discussion going.
Traders will indeed flock to ANP...but there is only so much Bollinger and Fibs talk we can take
Also, we have to remind ourselves that 80% of all M&A happens at P2 stage.
Your comments about a possible offer before P2 actually starting is worth archiving for future reference!
I know the Board are going long and saying the right things...but you just never know.
By late this year we’ll have more gene therapy results from Sarepta and also Pfizer’s program that started early this year.
If both of these come in with average results then it will be on like Donkey-Kong!
.
Well said @George1972 Stick around mate, we need to keep the FA...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |